Experimental Hematology
Volume 35, Issue 12 , Pages 1793-1800 , December 2007

P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors

  • Laura Connelly-Smith

      Affiliations

    • Department of Haematology, Nottingham University Hospitals, Nottingham, UK
    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Joanne Pattinson

      Affiliations

    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Martin Grundy

      Affiliations

    • Department of Haematology, Nottingham University Hospitals, Nottingham, UK
    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Shili Shang

      Affiliations

    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Claire Seedhouse

      Affiliations

    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Nigel Russell

      Affiliations

    • University of Nottingham, University Park, Nottingham, UK
    • ,
  • Monica Pallis

      Affiliations

    • Department of Haematology, Nottingham University Hospitals, Nottingham, UK
    • Corresponding Author InformationOffprint requests to: Monica Pallis, Ph.D., Department of Academic Haematology, Nottingham University Hospitals, City Hospital Campus, Clinical Sciences Building, 2nd Floor, Nottingham NG5 1PB, UK

Received 29 March 2007 ,Revised 19 July 2007 ,Accepted 23 July 2007.

References 

  1. Gottesman MM, Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett. 2006;580:998–1009
  2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene. 2003;22:7468–7485
  3. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219–234
  4. Schinkel AH, Mol CA, Wagenaar E, van Deemter L, Smit JJ, Borst P. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur J Cancer. 1995;31A:1295–1298
  5. Ruhl R, Sczech R, Landes N, Pfluger P, Kluth D, Schweigert FJ. Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane X receptor. Eur J Nutr. 2004;43:336–343
  6. Park SW, Lomri N, Simeoni LA, Fruehauf JP, Mechetner E. Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay. Cytometry A. 2003;53:67–78
  7. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425–430
  8. Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood. 1994;84:2689–2698
  9. Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood. 2003;101:3628–3634
  10. Banker DE, Mayer SJ, Li HY, Willman CL, Appelbaum FR, Zager RA. Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood. 2004;104:1816–1824
  11. Kornblau SM, Banker DE, Stirewalt D, et al. Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high dose Ara-C: a Phase 1 study. Blood. 2007;109:2999–3006
  12. Garrigues A, Escargueil AE, Orlowski S. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci U S A. 2002;99:10347–10352
  13. Debry P, Nash E, Neklason D, Metherall J. Role of multidrug resistance p-glycoproteins in cholesterol esterification. J Biol Chem. 1997;272:1026–1031
  14. Luker GD, Nilsson KR, Covey DF, Piwnica-Worms D. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J Biol Chem. 1999;274:6979–6991
  15. Lange Y, Steck TL. Cholesterol homeostasis. Modulation by amphiphiles. J Biol Chem. 1994;269:29371–29374
  16. Moore LB, Parks DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem. 2000;275:15122–15127
  17. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med. 2001;7:584–590
  18. Bailly J-D, Muller C, Jaffrezou J-P, et al. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Leukemia. 1995;9:799–807
  19. Vance DE, Weinstein DB, Steinberg D. Isolation and analysis of lipoproteins secreted by rat liver hepatocytes. Biochim Biophys Acta. 1984;792:39–47
  20. Gayet L, Dayan G, Barakat S, et al. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Biochemistry. 2005;44:4499–4509
  21. Pallis M, Das-Gupta E. Flow cytometric measurement of functional and phenotypic p-glycoprotein. In:  Blumenthal RD editors. Chemosensitivity. Totowa: Humana Press; 2005;p. 167–181
  22. Pallisgaard N, Clausen N, Schroder H, Hokland P. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer. 1999;26:355–365
  23. Pallis M, Turzanski T, Harrison G, et al. Use of standardised flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia. Br J Haematol. 1999;104:307–312
  24. Pallis M, Syan J, Russell NH. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34. Cytometry. 1999;37:308–313
  25. Ratnasinghe D, Phang JM, Yeh GC. Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer MCF-7 cells. Int J Oncol. 1998;13:79–84
  26. Santai CT, Fritz F, Roepe PD. Effects of ion gradients on H+ transport mediated by human MDR 1 protein. Biochemistry. 1999;38:4227–4234
  27. Levchenko A, Mehta BM, Spengler BA, et al. Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay. Anal Biochem. 1996;236:338–343
  28. Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 1991;51:3602–3609
  29. Leith CP, Kopecky KJ, Godwin J, et al. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study. Blood. 1997;89:3323–3329
  30. Leith CP, Kopecky KJ, Chen IM, et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood. 1999;94:1086–1099
  31. Metherall J, Li H, Waugh K. Role of multidrug resistance p-glycoproteins in cholesterol biosynthesis. J Biol Chem. 1996;271:2634–2640
  32. Field F, Born E, Murthy S, Mathur S. Transport of cholesterol from the endoplamic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. J Lipid Res. 1998;39:333–343
  33. Le Goff W, Settle M, Greene DJ, Morton RE, Smith JD. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis. J Lipid Res. 2006;47:51–58
  34. Pani A, Batetta B, Putzolu M, et al. MDR1, cholesterol esterification and cell growth: a comparative study in normal and multidrug-resistant KB cell lines. Cell Mol Life Sci. 2000;57:1094–1102
  35. Rodrigues AC, Curi R, Britto LR, et al. Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells. Biochim Biophys Acta. 2006;1760:1866–1873
  36. Dimitroulakos J, Yeger H. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells. Nat Med. 1996;2:326–333
  37. Dimitroulakos J, Nohynek D, Backway KL, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood. 1999;93:1308–1318
  38. Maksumova L, Ohnishi K, Muratkhodjaev F, et al. Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin. Leukemia. 2000;14:1444–1450

PII: S0301-472X(07)00457-2

doi: 10.1016/j.exphem.2007.07.017

Experimental Hematology
Volume 35, Issue 12 , Pages 1793-1800 , December 2007

Article Tools

* Image Usage & Resolution